BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9012453)

  • 1. Rb functions to inhibit apoptosis during myocyte differentiation.
    Wang J; Guo K; Wills KN; Walsh K
    Cancer Res; 1997 Feb; 57(3):351-4. PubMed ID: 9012453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
    Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
    Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.
    Jiang Z; Liang P; Leng R; Guo Z; Liu Y; Liu X; Bubnic S; Keating A; Murray D; Goss P; Zacksenhaus E
    Dev Biol; 2000 Nov; 227(1):8-41. PubMed ID: 11076674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation.
    Wang J; Walsh K
    Science; 1996 Jul; 273(5273):359-61. PubMed ID: 8662523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of expression and activity of distinct pRB, E2F, D-type cyclin, and CKI family members during terminal differentiation of P19 cells.
    Gill RM; Slack R; Kiess M; Hamel PA
    Exp Cell Res; 1998 Oct; 244(1):157-70. PubMed ID: 9770359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals.
    Vaziri C; Stice L; Faller DV
    Cell Growth Differ; 1998 Jun; 9(6):465-74. PubMed ID: 9663465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L; Wang Z; Decker RH; Chellappan SP; Fusaro G; Hirsch KG; Sankala HM; Dent P; Grant S
    Cancer Res; 2001 Mar; 61(6):2583-91. PubMed ID: 11289135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.
    Nonomura Y; Nagasaka K; Hagiyama H; Sekine C; Nanki T; Tamamori-Adachi M; Miyasaka N; Kohsaka H
    Arthritis Rheum; 2006 Jul; 54(7):2074-83. PubMed ID: 16802342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.
    Jori FP; Melone MA; Napolitano MA; Cipollaro M; Cascino A; Giordano A; Galderisi U
    Cell Death Differ; 2005 Jan; 12(1):65-77. PubMed ID: 15459751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cyclin-dependent kinase inhibitors in mammal cells].
    Jiang H; Wang YC
    Sheng Li Ke Xue Jin Zhan; 1996 Apr; 27(2):107-12. PubMed ID: 9592231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of cyclin-dependent kinase inhibitors in monolayer and spheroid cultures of tumorigenic and nontumorigenic fibroblasts.
    LaRue KE; Bradbury EM; Freyer JP
    Cancer Res; 1998 Mar; 58(6):1305-14. PubMed ID: 9515820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1.
    Halaban R; Cheng E; Zhang Y; Mandigo CE; Miglarese MR
    Oncogene; 1998 May; 16(19):2489-501. PubMed ID: 9627115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
    Divan A; Lawry J; Dunsmore IR; Parsons MA; Royds JA
    Cancer Res; 2001 Apr; 61(7):3157-63. PubMed ID: 11306502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functions of the cdk-cyclin kinase inhibitor p21WAF1.
    Boulaire J; Fotedar A; Fotedar R
    Pathol Biol (Paris); 2000 Apr; 48(3):190-202. PubMed ID: 10858953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
    Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
    Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate regulation of cell cycle and apoptosis during myogenesis.
    Walsh K
    Prog Cell Cycle Res; 1997; 3():53-8. PubMed ID: 9552406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase.
    Skapek SX; Rhee J; Spicer DB; Lassar AB
    Science; 1995 Feb; 267(5200):1022-4. PubMed ID: 7863328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell cycle exit upon myogenic differentiation.
    Walsh K; Perlman H
    Curr Opin Genet Dev; 1997 Oct; 7(5):597-602. PubMed ID: 9388774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.